Cargando…
CNS4 causes subtype‐specific changes in agonist efficacy and reversal potential of permeant cations in NMDA receptors
The NMDA subtype of glutamate receptor serves as an attractive drug target for the treatment of disorders evolving from hyper‐ or hypoglutamatergic conditions. Compounds that optimize the function of NMDA receptors are of great clinical significance. Here, we present the pharmacological characteriza...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245146/ https://www.ncbi.nlm.nih.gov/pubmed/37283007 http://dx.doi.org/10.1002/prp2.1107 |